Finanza

Notizie Discussioni Tecnici Stagionalità

Utile netto diluito per azionisti ordinari su TIBET WEIXINKANG MEDICINE CO LTD.

Dati annuali

2015

2016

2017

2018

2019

2020

2021

2022

2023

TTM

‪0,00‬

‪‪70,00 M‬‬

‪‪140,00 M‬‬

‪‪210,00 M‬‬

‪‪280,00 M‬‬

Periodo

Valore

Variazione

Variazione %

TTM

‪‪247,04 M‬‬

+‪‪33,03 M‬‬

+‪15,43‬%

2023

‪‪214,02 M‬‬

+‪‪37,06 M‬‬

+‪20,94‬%

2022

‪‪176,96 M‬‬

+‪‪81,05 M‬‬

+‪84,50‬%

2021

‪‪95,91 M‬‬

+‪‪37,49 M‬‬

+‪64,16‬%

2020

‪‪58,42 M‬‬

+‪‪2,75 M‬‬

+‪4,93‬%

2019

‪‪55,68 M‬‬

‪‪−17,76 M‬‬

‪−24,18‬%

2018

2017

2016

2015

Dati trimestrali

Q1 '17

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪25,00 M‬‬

‪‪50,00 M‬‬

‪‪75,00 M‬‬

‪‪100,00 M‬‬

Periodo

Valore

Variazione

Variazione %

Q3 '24

‪‪79,81 M‬‬

+‪‪11,26 M‬‬

+‪16,43‬%

Q2 '24

‪‪68,55 M‬‬

‪‪−26,37 M‬‬

‪−27,78‬%

Q1 '24

‪‪94,91 M‬‬

+‪‪91,14 M‬‬

+‪‪2,41 K‬‬%

Q4 '23

‪‪3,78 M‬‬

‪‪−72,46 M‬‬

‪−95,05‬%

Q3 '23

‪‪76,24 M‬‬

+‪‪2,48 M‬‬

+‪3,37‬%

Q2 '23

‪‪73,75 M‬‬

+‪‪13,51 M‬‬

+‪22,42‬%

Q1 '23

‪‪60,25 M‬‬

+‪‪34,28 M‬‬

+‪131,98‬%

Q4 '22

‪‪25,97 M‬‬

‪‪−22,05 M‬‬

‪−45,91‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19

Q1 '19

Q4 '18

Q3 '18

Q2 '18

Q1 '18

Q4 '17

Q3 '17

Q2 '17

Q1 '17